Literature DB >> 2783897

Interleukin-6 in synovial fluid from patients with arthritis.

A Waage1, C Kaufmann, T Espevik, G Husby.   

Abstract

Synovial fluid and serum from patients with rheumatoid arthritis, other inflammatory arthritides, and traumatic arthritis were assayed for the presence of interleukin-6 (IL-6) by means of an IL-6-dependent mouse hybridoma cell line. The cytokine was detected in all the samples of synovial fluid (range 50-22000 U/ml). IL-6 in synovial fluid was positively correlated (r = 0.58, P = 0.03) with the erythrocyte sedimentation rate in patients with inflammatory arthritis. In serum, the concentration of IL-6 was slightly elevated in some patients with rheumatoid arthritis. The results demonstrate that IL-6 is released into synovial fluid in joints affected by arthritis, and there appears to be an association between the levels of IL-6 and disease activity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2783897     DOI: 10.1016/0090-1229(89)90146-3

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  29 in total

Review 1.  Interleukin-6 and the acute phase response.

Authors:  P C Heinrich; J V Castell; T Andus
Journal:  Biochem J       Date:  1990-02-01       Impact factor: 3.857

2.  Human rheumatoid synovial cell stimulation by the membrane attack complex and other pore-forming toxins in vitro: the role of calcium in cell activation.

Authors:  R H Daniels; B D Williams; B P Morgan
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

3.  Localisation of intrahepatic interleukin 6 in patients with acute and chronic liver disease.

Authors:  S Kakumu; A Fukatsu; T Shinagawa; S Kurokawa; A Kusakabe
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

4.  The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Alvise Berti; Roscoe Warner; Kent Johnson; Divi Cornec; Darrell R Schroeder; Brian F Kabat; Carol A Langford; Cees G M Kallenberg; Philip Seo; Robert F Spiera; E William St Clair; Fernando C Fervenza; John H Stone; Paul A Monach; Ulrich Specks; Peter A Merkel
Journal:  J Autoimmun       Date:  2019-07-15       Impact factor: 7.094

Review 5.  Cytokines in rheumatoid arthritis. Potential targets for pharmacological intervention.

Authors:  Z Szekanecz; A E Koch; S L Kunkel; R M Strieter
Journal:  Drugs Aging       Date:  1998-05       Impact factor: 3.923

6.  Evaluation of interleukin-6 in rheumatoid arthritis as an activity criterion.

Authors:  T Sentürk; G Kinikli; M Turgay; H Tutkak; M Duman; G Tokgöz
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

7.  Circulating cytokine levels in patients with rheumatoid arthritis: results of a double blind trial with sulphasalazine.

Authors:  V A Danis; G M Franic; D A Rathjen; R M Laurent; P M Brooks
Journal:  Ann Rheum Dis       Date:  1992-08       Impact factor: 19.103

Review 8.  Interleukin-6 in autoimmune disease. Role of IL-6 in physiology and pathology of the immune defense.

Authors:  L Graeve; M Baumann; P C Heinrich
Journal:  Clin Investig       Date:  1993-08

9.  Human herpesvirus 6 induces interleukin-1 beta and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures.

Authors:  L Flamand; J Gosselin; M D'Addario; J Hiscott; D V Ablashi; R C Gallo; J Menezes
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

10.  Interleukin-6 in synovial fluid is closely associated with chronic synovitis in rheumatoid arthritis.

Authors:  U Sack; R W Kinne; T Marx; P Heppt; S Bender; F Emmrich
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.